1. Pharmacology, physiology, and mechanisms of incretin hormone action;Campbell;Cell Metab,2013
2. Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor;Cawston;Br J Pharmacol,2010
3. Emerging neuropeptide targets in inflammation: NPY and VIP;Chandrasekharan;Am J Physiol Gastrointest Liver Physiol,2013
4. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide;Harmar;Pharmacol Rev,1998
5. Structure–function of the G protein-coupled receptor superfamily;Katritch;Annu Rev Pharmacol Toxicol,2013